Yongin-si, South Korea

Sung Hak Lee

USPTO Granted Patents = 9 

Average Co-Inventor Count = 13.9

ph-index = 6

Forward Citations = 92(Granted Patents)


Location History:

  • Seoul, KR (2003 - 2004)
  • Yongin-si, KR (2004 - 2005)
  • Yongin, KR (2006)

Company Filing History:


Years Active: 2003-2006

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sung Hak Lee

Introduction

Sung Hak Lee is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, holding a total of nine patents. His work focuses on developing novel compounds and methods that enhance therapeutic efficacy.

Latest Patents

Among his latest patents, Lee has developed a 1,2,4-Triazole derivative, which includes a method for preparing the compound and a pharmaceutical composition containing it. This derivative is characterized by its formula and is designed to serve as an active ingredient in various medical applications. Additionally, he has created a novel crystalline organic acid salt of amlodipine, which boasts improved physiochemical properties. This patent also includes a preparation method and a pharmaceutical composition that incorporates this innovative salt.

Career Highlights

Sung Hak Lee has worked with notable companies such as CJ Corporation and Cheiljedang Corporation. His experience in these organizations has allowed him to refine his skills and contribute to the advancement of pharmaceutical sciences.

Collaborations

Throughout his career, Lee has collaborated with talented individuals, including Sung Hak Jung and Young Hoon Kim. These partnerships have fostered a creative environment that has led to the development of impactful inventions.

Conclusion

Sung Hak Lee's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and improve therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…